3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
2
Plasma cell
1
Other hematologic neoplasm
1
Myeloid
1
Breast
1
Conditions
Breast Neoplasms
28
Triple Negative Breast Neoplasms
4
Neoplasm Metastasis
2
Lymphoma, Non-Hodgkin
1
Inflammatory Breast Neoplasms
1
Hodgkin Disease
1
Disease
1
Carcinoma
1
Calcinosis
1
Brain Neoplasms
1
Interventions
Therapeutics
6
Cyclophosphamide
6
Flow Cytometry
5
Radiotherapy
4
Peripheral Blood Stem Cell Transplantation
4
Filgrastim
4
pembrolizumab
3
Psychiatric Rehabilitation
3
Polymerase Chain Reaction
3
Nivolumab
3
Immunoenzyme Techniques
3
Blood Specimen Collection
3
sargramostim
2
liposomal amphotericin B
2
durvalumab
2
copanlisib
2
belinostat
2
aldesleukin
2
Vorinostat
2
Surveys and Questionnaires
2
Stem Cell Factor
2
Rituximab
2
Ondansetron
2
Methylprednisolone
2
Melphalan
2
Itraconazole
2
Ipilimumab
2
Immunologic Techniques
2
Gemcitabine
2
Etoposide
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Hodgkin Disease
×
Magnetic Resonance Imaging
×
Breast
×
Clear all
NCT05595577
2026-03-20
PALS
Wake Forest University Health Sciences
Phase NA
Recruiting
110 enrolled